<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int Ophthalmol</journal-id>
      <journal-title-group>
        <journal-title>International Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0165-5701</issn>
      <issn pub-type="epub">1573-2630</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3021198</article-id>
      <article-id pub-id-type="pmid">20862519</article-id>
      <article-id pub-id-type="publisher-id">9397</article-id>
      <article-id pub-id-type="doi">10.1007/s10792-010-9397-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevention of age-related macular degeneration</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Wong</surname>
            <given-names>Ian Yat Hin</given-names>
          </name>
          <address>
            <email>ianyhwong@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koo</surname>
            <given-names>Simon Chi Yan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Clement Wai Nang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Eye Institute, University of Hong Kong, Hong Kong, Hong Kong </aff>
        <aff id="Aff2"><label>2</label>Tung Wah Eastern Hospital, Hong Kong, Hong Kong </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>23</day>
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <volume>31</volume>
      <issue>1</issue>
      <fpage>73</fpage>
      <lpage>82</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>1</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>4</day>
          <month>9</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract>
        <p>Age-related macular degeneration (AMD) is one of the leading causes of blindness in the developed world. Although effective treatment modalities such as anti-VEGF treatment have been developed for neovascular AMD, there is still no effective treatment for geographical atrophy, and therefore the most cost-effective management of AMD is to start with prevention. This review looks at current evidence on preventive measures targeted at AMD. Modalities reviewed include (1) nutritional supplements such as the Age-Related Eye Disease Study (AREDS) formula, lutein and zeaxanthin, omega-3 fatty acid, and berry extracts, (2) lifestyle modifications, including smoking and body-mass-index, and (3) filtering sunlight, i.e. sunglasses and blue-blocking intraocular lenses. In summary, the only proven effective preventive measures are stopping smoking and the AREDS formula.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>AREDS</kwd>
        <kwd>Age-related macular degeneration</kwd>
        <kwd>AMD</kwd>
        <kwd>Vitamin E</kwd>
        <kwd>Beta-carotene</kwd>
        <kwd>Neovascular AMD</kwd>
        <kwd>Yellow IOL</kwd>
        <kwd>Sunlight filtration</kwd>
        <kwd>Prevention</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>Age-related macular degeneration (AMD) is one of the leading causes of blindness in developed countries [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]; currently 11.5% of the population in the United States is affected [<xref ref-type="bibr" rid="CR1">1</xref>]. The exact pathogenesis of AMD remains unknown [<xref ref-type="bibr" rid="CR4">4</xref>], but one of the main components is thought to be oxidative stress [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]: the retina, because of its high oxygen concentration and intense light exposure, is susceptible to damage by oxidative stress [<xref ref-type="bibr" rid="CR6">6</xref>]. Early stages of AMD can be asymptomatic but can cause severe impairment of central vision in late stages. Details of the most up-to-date classification of AMD are given in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. There have been some promising new treatments in recent years since the emergence of anti-vascular endothelial growth factor (anti-VEGF) agents, and numerous pivotal studies have proven their effectiveness in controlling neovascular AMD [<xref ref-type="bibr" rid="CR7">7</xref>]. However, at the moment, costs for these drugs are high and patients may have to undergo multiple injections.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Categorization of age-related macular degeneration (AMD) according to the Age-Related Eye Disease Study (AREDS) guidelines</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Brief description</th><th align="left">Clinical features</th><th align="left">Visual acuity</th></tr></thead><tbody><tr><td align="left">Category 1</td><td align="left">Free of AMD in both eyes</td><td align="left">&lt;5 small drusen in one or both eyes</td><td align="left">20/32 or better in both eyes</td></tr><tr><td align="left">Category 2</td><td align="left">Mild to borderline AMD in one or both eyes</td><td align="left">Multiple small or intermediate drusen in one or both eyes<break/>Pigment abnormalities in one or both eyes</td><td align="left">20/32 or better in both eyes</td></tr><tr><td align="left">Category 3</td><td align="left">Absence of advanced AMD in both eyes</td><td align="left">Intermediate or large drusen<break/>Geographical atrophy<break/>Features not involving central macular</td><td align="left">20/32 or better in better eye</td></tr><tr><td align="left">Category 4</td><td align="left">Advanced AMD in one eye</td><td align="left">Advanced AMD or geographical atrophy in worse eye<break/>No such features in better eye</td><td align="left">20/32 or better in better eye</td></tr></tbody></table><table-wrap-foot><p><italic>Key</italic>: Small drusen, &lt;63&#xA0;&#x3BC;m in diameter (disc diameter around 1500&#xA0;&#x3BC;m); intermediate drusen, 63&#x2013;124 &#x3BC;m in diameter; large drusen, &gt;125 &#x3BC;m in diameter; pigment abnormalities refer to either hyperpigmentation or depigmentation</p></table-wrap-foot></table-wrap></p>
      <p>Taking in consideration the ever-growing population, the incidence of AMD will only increase. In the United States alone, it is thought that the incidence may double in the next 20 years [<xref ref-type="bibr" rid="CR1">1</xref>], and so will the resources and effort spent in the area. Even if anti-VEGF agents are made cheaper and more available, more and more patients will have to rely on them, and as a result the burden on the healthcare system will be increased [<xref ref-type="bibr" rid="CR8">8</xref>]. It may be more economical to tackle AMD with prevention. Studies done on AMD prevention usually fall into one of three areas: (1) nutritional supplements, (2) lifestyle modifications, (3) filtering sunlight. It is vital that ophthalmologists and general practitioners be aware of the latest and updated evidence. In this article we hope to provide an overview of current opinions on the prevention of AMD.</p>
    </sec>
    <sec id="Sec2" sec-type="methods">
      <title>Methods</title>
      <p>An evidence-based approach was adopted in the review process. The literature up to December 2009 was searched for keywords &#x2018;age-related macular degeneration&#x2019;, &#x2018;macular&#x2019;, &#x2018;AMD&#x2019;, &#x2018;antioxidants&#x2019;, &#x2018;mineral supplements&#x2019;, &#x2018;dietary supplements&#x2019;, and &#x2018;prevention&#x2019;. We used the databases Medline, The Cochrane Library, Embase.com, Web of Knowledge, and Google Scholar. The search was limited to studies in human subjects, in English. Strength of evidence and rating of recommendation were assessed according to the method described previously [<xref ref-type="bibr" rid="CR9">9</xref>], and are summarized in Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>.</p>
    </sec>
    <sec id="Sec3">
      <title>Evidence synthesis</title>
      <sec id="Sec4">
        <title>Nutritional supplements</title>
        <p>Most studies focused on four types of supplements:<list list-type="order"><list-item><p>AREDS or AREDS-like formulas,</p></list-item><list-item><p>Lutein and zeaxanthin,</p></list-item><list-item><p>Omega-3 fatty acids,</p></list-item><list-item><p>Berry extracts.</p></list-item></list></p>
        <sec id="Sec5">
          <title>AREDS or AREDS-like formulas</title>
          <p>The Age-Related Eye Disease Study (AREDS) was designed to investigate whether active treatment with supplements such as vitamins and minerals can reduce the risk of advanced AMD. The main components of the formula were vitamin A (as beta-carotene), vitamin C, vitamin E, and zinc. These ingredients were thought to exert a protective effect on retinal cells by counteracting oxidative stresses [<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>]. The formula was a type of active treatment and therefore the dosages of ingredients were much higher than the Dietary Reference Intake (DRI), which is a system of nutrition recommendations from the Institute of Medicine of the USA National Academy [<xref ref-type="bibr" rid="CR16">16</xref>]. For instance, the amount of vitamin C included in the AREDS formula was 500&#xA0;mg per day, whereas the DRI for an adult is only 90&#xA0;mg per day (a medium-sized orange contains around 70&#xA0;mg of vitamin C, and therefore one has to eat almost seven or eight oranges to obtain 500&#xA0;mg of vitamin C). A detailed comparison of nutrient contents between the AREDS formula and common fruits is given in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Dosages of the Age-Related Eye Disease Study (AREDS) type formulas compared with common fruit items</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Nutrient</th><th align="left">AREDS [<xref ref-type="bibr" rid="CR17">17</xref>]</th><th align="left">DRI<sup>a</sup></th><th align="left">Orange<sup>b</sup></th><th align="left">Apple<sup>b</sup></th><th align="left">Blueberry<sup>b</sup></th><th align="left">Banana<sup>b</sup></th><th align="left">Mango<sup>b</sup></th><th align="left">Strawberry<sup>b</sup></th><th align="left">Watermelon<sup>b</sup></th></tr></thead><tbody><tr><td align="left">Vitamin A<sup>c</sup> (IU)</td><td align="left">5000</td><td align="left">3000</td><td align="left">225</td><td align="left">54</td><td align="left">22</td><td align="left">64</td><td align="left">765</td><td align="left">18</td><td align="left">569</td></tr><tr><td align="left">Vitamin C (mg)</td><td align="left">500</td><td align="left">90</td><td align="left">53.2</td><td align="left">4.6</td><td align="left">0.7</td><td align="left">8.7</td><td align="left">27.7</td><td align="left">13.7</td><td align="left">8.1</td></tr><tr><td align="left">Vitamin E (mg)</td><td align="left">400</td><td align="left">15</td><td align="left">0.1</td><td align="left">0.18</td><td align="left">0.23</td><td align="left">0.10</td><td align="left">1.12</td><td align="left">0.1</td><td align="left">0.05</td></tr><tr><td align="left">Zinc (mg)</td><td align="left">80</td><td align="left">11</td><td align="left">0.07</td><td align="left">0.04</td><td align="left">0.1</td><td align="left">0.15</td><td align="left">0.04</td><td align="left">0.06</td><td align="left">0.1</td></tr><tr><td align="left">Copper (mg)</td><td align="left">2</td><td align="left">0.9</td><td align="left">0.045</td><td align="left">0.027</td><td align="left">0.12</td><td align="left">0.078</td><td align="left">0.11</td><td align="left">0.03</td><td align="left">0.042</td></tr><tr><td align="left">Lutein/zeaxanthin (&#x3BC;g)</td><td align="left">None</td><td align="left">No data</td><td align="left">129</td><td align="left">29</td><td align="left">33</td><td align="left">22</td><td align="left">0</td><td align="left">9</td><td align="left">8</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Dietary Reference Intakes from the Institute of Medicine [<xref ref-type="bibr" rid="CR16">16</xref>]</p><p><sup>b</sup>Nutrient contents of common fruit items are measured per 100&#xA0;g</p><p><sup>c</sup>Vitamin A as beta-carotene</p></table-wrap-foot></table-wrap></p>
          <p>Subjects were categorized initially according to the suggested grading system [<xref ref-type="bibr" rid="CR17">17</xref>], and then were asked to take either the supplements or placebo on twice a day. The progress of 3,640 subjects was monitored for an average of 6.3&#xA0;years. In essence, the results showed a 25% reduction in risk of progression to advanced AMD if recommended doses of antioxidants and zinc were taken daily. However, this was seen in category 3 or 4 patients only, probably because of the higher natural risk of progression to advanced AMD. Results were not significant for category 2 or 1, i.e. those with small drusen only (the 5-year risk of progression to advanced AMD in category 2 was only 1.3% and in category 1 &lt;1%).</p>
          <p>However, in the USA 80% of people over age 70 fall into category 1 or 2, and hence most people would probably not benefit from the AREDS formula. Therefore it was only recommended to high-risk patients (i.e. category 3 or 4). For low risk patients (i.e. category 1 or 2), recommendation was deferred until indicated [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
          <p>Potential risks of the AREDS formula include kidney stones from vitamin C; fatigue, muscle weakness, decreased thyroid function, and increased hemorrhagic stroke risk from vitamin E; increased lung cancer risk in smokers and yellow discoloration of skin from beta-carotene; and anemia, decreased serum high-density lipoprotein cholesterol, and stomach upset from zinc [<xref ref-type="bibr" rid="CR18">18</xref>]. Despite numerous potential side effects, the only documented statistically significant ones were increased genitourinary symptoms, increased self-reported anemia, and yellow discoloration of skin. Although there was an increase in self-reported anemia, no significant change in blood hematocrit level was found. Smokers were discouraged from taking pills containing beta-carotene, so an increased risk of lung cancer with beta-carotene was not addressed in the AREDS, but it has already been established in two other trials [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Nevertheless, the few side effects were minor and the formula was otherwise considered safe. In any case, patients should always be informed of the risks and when significant contraindications exist (smoking, vascular diseases, hyperlipidemia, risk of hemorrhage, etc.), they should be discouraged from taking the formula.</p>
          <p>Instead of an active supplementation formula, some have proposed an enriched diet alone. The Rotterdam Study investigated the effect of a vitamin- and mineral-rich diet alone in the prevention of AMD [<xref ref-type="bibr" rid="CR21">21</xref>]. In comparison to the AREDS, no active interventions were given. Baseline dietary content was assessed, and followed up for possible development of AMD. The study found that an above-median intake of vitamin C and E, beta-carotene, and zinc was associated with a striking 35% decrease in incident AMD [<xref ref-type="bibr" rid="CR21">21</xref>]. They concluded that such a diet should be recommended to those with early signs of AMD or those with a strong family history.</p>
          <p>A recent meta-analysis carried out by the Cochrane Collaboration reviewed the evidence and concluded that both these recommendations were sound but patients should nevertheless be warned of potential harmful effects, particularly those who smoke or who have vascular diseases [<xref ref-type="bibr" rid="CR22">22</xref>]. Since patients take these pills on a prophylactic basis, it is undesirable to have complications arising.</p>
        </sec>
        <sec id="Sec6">
          <title>Lutein and zeaxanthin</title>
          <p>Also of great interest is the antioxidant balance among macular pigments, mainly lutein and its stereo-isomer, zeaxanthin. These carotenoids exist in high concentrations in the macula, hence its yellowish color. In vitro studies have shown that both protect the retina from oxidative stress [<xref ref-type="bibr" rid="CR23">23</xref>]. These carotenoids act in biological systems as (1) an important structural molecule in cell membranes, (2) a short-wavelength light filter, (3) a keeper of the redox balance, and (4) a modulator in signal transduction pathways [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. However, the human body is not capable of lutein synthesis; it can only be obtained from diet. Hence, supplementing the body with lutein may offer protection against AMD. However, these were not included in the AREDS because neither of the two substances was ready for manufacturing as a research formula [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
          <p>The Carotenoids in Age-Related Eye Disease Study (CAREDS) followed 1,787 American women aged 50&#x2013;79 for 4&#x2013;7&#xA0;years [<xref ref-type="bibr" rid="CR26">26</xref>]. Subjects were divided according to their average intake of dietary lutein and zeaxanthin, but here were no statistical differences between the amount of lutein and zeaxanthin they took and the risk of development of AMD.</p>
          <p>Conversely, two other studies were in favor of the hypothesis. The cohort Pathologies Oculaires Li&#xE9;es &#xE0; l&#x2019;Age (POLA) measured actual plasma carotenoids levels from 899 subjects and correlated them with risk of AMD. A striking reduction in risk was found in those with a high plasma level: the odds ratios were 0.31 and 0.07 for lutein and zeaxanthin, respectively [<xref ref-type="bibr" rid="CR27">27</xref>]. This was in agreement with another similar study in the UK, where a high plasma zeaxanthin was associated with a 50% reduction in risk of AMD [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
          <p>The US Food and Drug Administration (FDA) denied a link between the carotenoids and AMD protection after reviewing some interventional and observational randomized studies [<xref ref-type="bibr" rid="CR29">29</xref>]. In view of the contradicting results, the National Eye Institute (Bethesda, Maryland, USA) launched the Age-Related Eye Disease Study 2 (AREDS2) in autumn of 2006, hoping to answer this question. As well as carotenoids, it also studies omega-3 [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. It also modifies the original formula by eliminating beta-carotene, which increases the risk of lung cancer in smokers. The proposed study end time is late 2012. In the meantime, no evidence-based conclusion can be reached.</p>
          <p>Although not yet proven for benefits, many manufacturers have been including lutein and zeaxanthin in their supplements, many of which are available over the counter. In 2006, the Council for Responsible Nutrition (CRN) in Washington DC reviewed the risk profile of lutein and concluded that the only documented side effect is yellow discoloration of skin, characterized by high dermal caroteinoid levels. This condition is reversible and benign and there were no other adverse events [<xref ref-type="bibr" rid="CR32">32</xref>]. The CRN also suggested a daily lutein upper level of supplementation (ULS) of 20&#xA0;mg. Lutein and zeaxanthin carry potential benefits, and have minimal side effects. For those who are keen and are at risk of AMD, they may offer some protection.</p>
        </sec>
        <sec id="Sec7">
          <title>Omega-3 fatty acids</title>
          <p>The role of omega-3 fatty acids in reducing the incidence of cardiovascular diseases and strokes has been well established [<xref ref-type="bibr" rid="CR33">33</xref>]. For instance, the American Heart Association recommends the intake of omega-3 fatty acids in the form of either fish or fish oil capsule supplements for cardiovascular benefits [<xref ref-type="bibr" rid="CR34">34</xref>]. Recently, its role in AMD has also been investigated. Docosahexaenoic acid (DHA) is a type of omega-3 fatty acid present in high concentration in the photoreceptor segment of the retina. It is constantly being shed and reformed in the normal visual cycle, and has been shown to reduce inflammation and regulate autoimmune responses [<xref ref-type="bibr" rid="CR35">35</xref>&#x2013;<xref ref-type="bibr" rid="CR40">40</xref>], which in turn prevents AMD. Hodge et al. carried out a meta-analysis and concluded that evidence so far was inconsistent and not randomized [<xref ref-type="bibr" rid="CR41">41</xref>]. Larger randomized controlled trials are needed before conclusions can be drawn.</p>
          <p>More recently, the US Twin Study of Age-Related Macular Degeneration (USTS) investigated the relationship among 681 twins, and found that fish consumption and omega-3 fatty acid intake reduced the risk of AMD [<xref ref-type="bibr" rid="CR42">42</xref>], by an estimated 22% if omega-3 was high. However, the study was not randomized and hence its impact is limited.</p>
          <p>Because of the potential antithrombotic effect of fish oil, the risk of hemorrhagic stroke is potentially increased [<xref ref-type="bibr" rid="CR43">43</xref>]. Clinical studies have demonstrated that even with concurrent administration of agents like warfarin and aspirin, a high dose of fish oil does not significantly increase the risk of bleeding [<xref ref-type="bibr" rid="CR44">44</xref>&#x2013;<xref ref-type="bibr" rid="CR46">46</xref>]. Another safety concern is environmental contaminants such as mercury, which is commonly found in fish; high consumption of fish or fish oil capsules may pose potential health threats. The FDA issued an advisory statement recommending that pregnant women, breast-feeding mothers and children avoid eating certain types of seafood high in mercury [<xref ref-type="bibr" rid="CR47">47</xref>]. The risk is still low and is limited to certain types of fish such as golden bass, shark, king mackerel, and swordfish [<xref ref-type="bibr" rid="CR33">33</xref>]. Fish oil supplements are generally considered safe because most industrial purification processes eliminate these toxins [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p>
          <p>The risk of taking omega-3 fatty acids either from dietary fish or fish oil supplements is low, and the potential benefits outweigh the risks. With the proven cardiovascular benefits, consumption of fish or fish oil supplements remains a reasonable and safe recommendation.</p>
        </sec>
        <sec id="Sec8">
          <title>Berry extracts</title>
          <p>The interest in berry extracts grew from their antioxidant properties. Probably the most notable member of the berry family is blueberry, which ranked first in antioxidant properties among 100 common food items published by the United States Department of Agriculture assays [<xref ref-type="bibr" rid="CR50">50</xref>]. As far as ophthalmology is concerned, its antioxidant strength helps reduce risk of AMD, and improves night vision. Many berry extract products claim to protect eyes from AMD. Another berry, wolfberry, better known as &#x2018;goji berry&#x2019;, which has been long used in Traditional Chinese Medicine (TCM), is also known for its eye-protecting properties [<xref ref-type="bibr" rid="CR51">51</xref>].</p>
          <p>Anthocyanin is commonly present, and in plant studies it was found to absorb blue-green light and protect cells from light stress [<xref ref-type="bibr" rid="CR52">52</xref>]. Other laboratory studies have shown that it can theoretically protect eyes from degenerative diseases like AMD [<xref ref-type="bibr" rid="CR53">53</xref>&#x2013;<xref ref-type="bibr" rid="CR55">55</xref>]. Others also suggested anti-angiogenic and anti-cancer properties in anthocyanin [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. However, at the moment evidence is limited to the laboratory level. The precise dosage and frequency remains uncertain, and potential toxicity and long-term side effects still require exploration.</p>
          <p>Currently there are no legal requirements for quality control of these extracts. Most of these products need not disclose their exact content and production method. At the moment, berry extracts should not be recommended.</p>
        </sec>
      </sec>
      <sec id="Sec9">
        <title>Lifestyle modifications</title>
        <sec id="Sec10">
          <title>Smoking cessation</title>
          <p>The only established causative factor for AMD is smoking, which has been linked to increased oxidative stress, platelet aggregation, higher fibrinogen level, and reduced plasma high-density lipoprotein and antioxidant levels [<xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR60">60</xref>].</p>
          <p>In AREDS Report No. 19, subjects who smoke were found to have a higher risk of progression to advanced AMD. For 10 pack-years or higher smokers, the odds ratio for advanced AMD was 1.55 [<xref ref-type="bibr" rid="CR61">61</xref>]. Results of the US Twin Study showed that current smokers had a 1.9-fold increased risk of having AMD, and ex-smokers still had a 1.7-fold increased risk [<xref ref-type="bibr" rid="CR42">42</xref>]. If smokers take supplements containing beta-carotene, the risk of lung cancer is further increased [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. All smokers should be advised to stop.</p>
        </sec>
        <sec id="Sec11">
          <title>Body mass index (BMI)</title>
          <p>In the AREDS, a higher risk of the geographical atrophy type of AMD was seen in subjects with higher BMI [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. The odds ratio was 1.93 in obese individuals (obese BMI&#xA0;&#x2265;&#xA0;30&#xA0;kg/m [<xref ref-type="bibr" rid="CR2">2</xref>], normal BMI 18.5&#x2013;24.9&#xA0;kg/m [<xref ref-type="bibr" rid="CR2">2</xref>]). Another study by Seddon et al. also produced similar results [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
        </sec>
      </sec>
      <sec id="Sec12">
        <title>Reducing light exposure</title>
        <sec id="Sec13">
          <title>Sunglasses</title>
          <p>Some studies have suggested that sunlight exposure may contribute to AMD [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR73">73</xref>]. The Beaver Dam Eye Study (BDES) was a population-based cohort study measuring the amount of sunlight exposure and incidence of AMD in 2,764 subjects over a 10-year period [<xref ref-type="bibr" rid="CR74">74</xref>]. The BDES found that extended sunlight exposure was associated with higher incidence of early AMD. However, the protective effect of sunglasses was only marginal, and the data were reported on a subjective basis.</p>
          <p>More supporting evidence comes from reports on the incidence of AMD after cataract surgery and intraocular lens (IOL) implantation [<xref ref-type="bibr" rid="CR75">75</xref>&#x2013;<xref ref-type="bibr" rid="CR77">77</xref>]. Human crystalline lens turns yellow with age and has been proven to protect the retina from harmful ultraviolet (UV) blue or blue-green phototoxicity [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. When the crystalline lens is removed during surgery, the implanted IOL does not provide equivalent theoretical protection in vivo [<xref ref-type="bibr" rid="CR79">79</xref>]. For those who have had cataract surgery, wearing sunglasses in outdoor areas may provide protection in this regard.</p>
        </sec>
        <sec id="Sec14">
          <title>Spectral filtering IOLs</title>
          <p>A theoretical link has been proposed between phototoxicity and cataract extraction [<xref ref-type="bibr" rid="CR80">80</xref>]. Most modern-day IOLs mimic the crystalline lens in filtering the harmful UV spectrum of 300&#x2013;400&#xA0;nm [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. The human crystalline lens turns yellow with age, thereby blocking blue light (400&#x2013;500&#xA0;nm), while IOLs tend to be transparent [<xref ref-type="bibr" rid="CR82">82</xref>].</p>
          <p>In the Chesapeake Bay Watermen Study, a significant correlation between blue or visible light exposure and AMD was found [<xref ref-type="bibr" rid="CR68">68</xref>]. In fact, after cataract extraction, blue light exposure is greater than at any other point in life [<xref ref-type="bibr" rid="CR83">83</xref>].</p>
          <p>Among the blue-light blocking properties of modern IOLs (better known as &#x2018;Yellow IOLs&#x2019;), transmittance mimics that of a human adult crystalline lens. One example is the AcrySof<sup>&#xAE;</sup> Natural IOL by Alcon (Fort Worth, Texas, USA), which partially attenuates violet light (400&#x2013;440&#xA0;nm) [<xref ref-type="bibr" rid="CR84">84</xref>], and blocks 50% of blue light at 450&#xA0;nm and 25% at 480&#xA0;nm [<xref ref-type="bibr" rid="CR85">85</xref>]. In contrast, conventional transparent IOLs transmit 90% of light &gt;400&#xA0;nm [<xref ref-type="bibr" rid="CR82">82</xref>]. Therefore these yellow IOLs may theoretically protect the macula from phototoxicity.</p>
          <p>Concerns have been raised that these yellow IOLs attenuate visual performances under scotopic conditions (defined as lighting levels as experienced on a moonless night with only starlight), because blue light, which is more informative in this environment, is being partially filtered [<xref ref-type="bibr" rid="CR82">82</xref>]. Furthermore, some raised the issue of possible differences in color perception. For instance, driving at night is considered a mesopic task [<xref ref-type="bibr" rid="CR86">86</xref>], which refers to lighting conditions under a quarter of a full moon [<xref ref-type="bibr" rid="CR87">87</xref>]. Even under scotopic conditions, contrast sensitivity is greatest around the 507&#xA0;nm wavelength, and the AcrySof Natural IOL transmits 85% of light at this wavelength, as compared to 90% with conventional transparent IOLs, and only around 60% in a young adult natural crystalline lens [<xref ref-type="bibr" rid="CR78">78</xref>]. In fact, some studies even reported increased contrast sensitivity with the yellow IOLs [<xref ref-type="bibr" rid="CR88">88</xref>&#x2013;<xref ref-type="bibr" rid="CR90">90</xref>].</p>
          <p>Cionni used the Farnsworth 100-Hue test in subjects who had undergone bilateral yellow IOL implantation, and found no significant changes in terms of color perception [<xref ref-type="bibr" rid="CR91">91</xref>]. Comparison was also made with those who had a yellow IOL implanted in one eye, and a transparent IOL in the other, and found no significant alternations [<xref ref-type="bibr" rid="CR92">92</xref>]. Hence for most patients a yellow IOL may offer theoretical protection from AMD.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec15">
      <title>Summary and conclusions</title>
      <p>A systematic review of evidence on the prevention of age-related macular degeneration was made. A summary of recommendations is given in Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>. The AREDS formula remains the only A-rated recommendation so far. When dealing with patients, it is the responsibility of the practitioner to fully explain the nature of supplements and potential side effects from long-term regular intake, especially the increased risk of lung cancer in smokers. Any misconceptions should be addressed and rectified. It is also necessary to remind patients that even when taking the AREDS formula, AMD can still occur. Patients should be taught self-monitoring methods and undergo regular fundal examinations by qualified ophthalmologists. The importance of this cannot be over-emphasized.<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Summary of recommendations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Category</th><th align="left">Study</th><th align="left">Recommendation</th><th align="left">Strength of evidence<sup>a</sup></th><th align="left">Rating of recommendation<sup>a</sup></th></tr></thead><tbody><tr><td align="left" colspan="5">Nutritional supplements</td></tr><tr><td align="left" rowspan="2">&#xA0;AREDS formula</td><td align="left">AREDS</td><td align="left">Regular intake may reduce risk of neovascular AMD</td><td align="left">I</td><td align="left">B</td></tr><tr><td align="left">Cochrane [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left">Regular intake may reduce risk of neovascular AMD</td><td align="left">I</td><td align="left">A</td></tr><tr><td align="left" rowspan="4">&#xA0;Lutein and zeaxanthin</td><td align="left">AREDS2</td><td align="left">Not yet available</td><td align="left">n/a</td><td align="left">n/a</td></tr><tr><td align="left">CAREDS</td><td align="left">No difference</td><td align="left">II</td><td align="left">C</td></tr><tr><td align="left">POLA</td><td align="left">Higher lutein and zeaxanthin reduced risk of AMD</td><td align="left">II</td><td align="left">C</td></tr><tr><td align="left">Gale et al. [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td align="left">Higher lutein and zeaxanthin reduced risk of AMD</td><td align="left">II</td><td align="left">C</td></tr><tr><td align="left" rowspan="2">&#xA0;Omega-3</td><td align="left">AREDS2</td><td align="left">Not yet available</td><td align="left">n/a</td><td align="left">n/a</td></tr><tr><td align="left">USTS</td><td align="left">Higher omega-3 intake reduced risk of AMD</td><td align="left">II</td><td align="left">C</td></tr><tr><td align="left">&#xA0;Berry extracts</td><td align="left">None</td><td align="left">n/a</td><td align="left">n/a</td><td align="left">n/a</td></tr><tr><td align="left" colspan="5">Life style</td></tr><tr><td align="left" rowspan="2">&#xA0;Smoking</td><td align="left">AREDS</td><td align="left">Smokers had higher risk of AMD</td><td align="left">I</td><td align="left">B</td></tr><tr><td align="left">USTS</td><td align="left">Smokers had higher risk of AMD</td><td align="left">II</td><td align="left">C</td></tr><tr><td align="left">&#xA0;BMI</td><td align="left">AREDS</td><td align="left">Higher BMI was associated with higher risk of AMD</td><td align="left">I</td><td align="left">B</td></tr><tr><td align="left" colspan="5">Sunlight filtering</td></tr><tr><td align="left">&#xA0;Sunglasses</td><td align="left">BDES</td><td align="left">Benefit of sunglasses use against AMD marginal</td><td align="left">II</td><td align="left">C</td></tr><tr><td align="left">&#xA0;Yellow IOLs</td><td align="left">None</td><td align="left">n/a</td><td align="left">n/a</td><td align="left">n/a</td></tr></tbody></table><table-wrap-foot><p><italic>n/a</italic> data not available, <italic>AREDS</italic> Age-Related Eye Disease Study [<xref ref-type="bibr" rid="CR17">17</xref>], <italic>AREDS2</italic> Age-Related Eye Disease Study 2 [<xref ref-type="bibr" rid="CR31">31</xref>], <italic>CAREDS</italic> Carotenoids in Age-Related Eye Disease Study [<xref ref-type="bibr" rid="CR26">26</xref>], <italic>POLA</italic> &#x2018;Pathologies Oculaires Li&#xE9;es &#xE0; l&#x2019;Age&#x2019; study [<xref ref-type="bibr" rid="CR27">27</xref>], <italic>USTS</italic> United States Twins Study [<xref ref-type="bibr" rid="CR42">42</xref>], <italic>BDES</italic> Beaver Dam Eye Study [<xref ref-type="bibr" rid="CR66">66</xref>]</p><p><sup>a</sup>Strength of evidence and rating of recommendation rated according to method described previously [<xref ref-type="bibr" rid="CR9">9</xref>]</p></table-wrap-foot></table-wrap></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Open Access</title>
      <p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Eye Disease Prevalence Research Group</collab>
          </person-group>
          <article-title>Prevalence of age-related macular degeneration in the United States</article-title>
          <source>Arch Ophthalmol</source>
          <year>2004</year>
          <volume>122</volume>
          <fpage>564</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.122.4.564</pub-id>
          <pub-id pub-id-type="pmid">15078675</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wormald</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Is the incidence of registrable age-related macular degeneration increasing?</article-title>
          <source>Br J Ophthalmol</source>
          <year>1996</year>
          <volume>80</volume>
          <fpage>9</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.80.1.9</pub-id>
          <pub-id pub-id-type="pmid">8664242</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>VanNewkirk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weih</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the visual impairment project</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>960</fpage>
          <lpage>967</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00554-1</pub-id>
          <pub-id pub-id-type="pmid">11320028</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bressler</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Age related macular degeneration. New hope for a common problem comes from photodynamic therapy</article-title>
          <source>BMJ</source>
          <year>2000</year>
          <volume>321</volume>
          <fpage>1425</fpage>
          <lpage>1427</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.321.7274.1425</pub-id>
          <pub-id pub-id-type="pmid">11110721</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zarbin</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Current concepts in the pathogenesis of age-related macular degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>2004</year>
          <volume>122</volume>
          <fpage>598</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.122.4.598</pub-id>
          <pub-id pub-id-type="pmid">15078679</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beatty</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Phil</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Henson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Boulton</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The role of oxidative stress in the pathogenesis of age-related macular degeneration</article-title>
          <source>Surv Ophthalmol</source>
          <year>2000</year>
          <volume>45</volume>
          <fpage>115</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="doi">10.1016/S0039-6257(00)00140-5</pub-id>
          <pub-id pub-id-type="pmid">11033038</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenfeld</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Heier</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ranibizumab for neovascular age-related macular degeneration</article-title>
          <source>N Engl J Med</source>
          <year>2006</year>
          <volume>355</volume>
          <fpage>1419</fpage>
          <lpage>1431</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa054481</pub-id>
          <pub-id pub-id-type="pmid">17021318</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>OP</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Age-related macular degeneration: the costs to society and the patient</article-title>
          <source>Curr Opin Ophthalmol</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>201</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="doi">10.1097/ICU.0b013e32810c8df4</pub-id>
          <pub-id pub-id-type="pmid">17435426</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minckler</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Evidence-based ophthalmology series and content-based continuing medical education for the journal</article-title>
          <source>Ophthalmology</source>
          <year>2000</year>
          <volume>107</volume>
          <fpage>9</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(99)00085-8</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seddon</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ajani</surname>
              <given-names>UA</given-names>
            </name>
            <name>
              <surname>Sperduto</surname>
              <given-names>RD</given-names>
            </name>
            <collab>Eye Disease Case-Control Study Group</collab>
            <etal/>
          </person-group>
          <article-title>Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration</article-title>
          <source>JAMA</source>
          <year>1994</year>
          <volume>272</volume>
          <fpage>1413</fpage>
          <lpage>1420</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.272.18.1413</pub-id>
          <pub-id pub-id-type="pmid">7933422</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snellen</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Verbeek</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Hoogen</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Cruysberg</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hoyng</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Neovascular age-related macular degeneration and its relationship to antioxidant intake</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2002</year>
          <volume>80</volume>
          <fpage>368</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="doi">10.1034/j.1600-0420.2002.800404.x</pub-id>
          <pub-id pub-id-type="pmid">12190777</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Flowerdew</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Brody</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Tso</surname>
              <given-names>MO</given-names>
            </name>
          </person-group>
          <article-title>Factors associated with age-related macular degeneration: an analysis of data from the first National Health and Nutrition Examination Survey</article-title>
          <source>Am J Epidemiol</source>
          <year>1988</year>
          <volume>128</volume>
          <fpage>700</fpage>
          <lpage>710</lpage>
          <pub-id pub-id-type="pmid">3421236</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>VandenLangenberg</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Mares-Perlman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Palta</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study</article-title>
          <source>Am J Epidemiol</source>
          <year>1998</year>
          <volume>148</volume>
          <fpage>204</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">9676703</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newsome</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Swartz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leone</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Elston</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Oral zinc in macular degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>1988</year>
          <volume>106</volume>
          <fpage>192</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="pmid">3277606</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moriarty-Craige</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>K-N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration</article-title>
          <source>Am J Ophthalmol</source>
          <year>2007</year>
          <volume>143</volume>
          <fpage>206</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajo.2006.09.056</pub-id>
          <pub-id pub-id-type="pmid">17157802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Dietary Reference Intakes, Institute of Medicine of the National Academies website. <ext-link ext-link-type="uri" xlink:href="http://www.iom.edu/CMS/3788/4574.aspx">http://www.iom.edu/CMS/3788/4574.aspx</ext-link>. Accessed 15 December 2007</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">The Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 119:1417&#x2013;1436</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Peto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bird</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The epidemiology of age-related macular degeneration</article-title>
          <source>Am J Ophthalmol</source>
          <year>2004</year>
          <volume>137</volume>
          <fpage>486</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajo.2003.11.069</pub-id>
          <pub-id pub-id-type="pmid">15013873</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Omenn</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Thornquist</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease</article-title>
          <source>N Engl J Med</source>
          <year>1996</year>
          <volume>334</volume>
          <fpage>1150</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199605023341802</pub-id>
          <pub-id pub-id-type="pmid">8602180</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group</collab>
          </person-group>
          <article-title>The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers</article-title>
          <source>N Engl J Med</source>
          <year>1994</year>
          <volume>330</volume>
          <fpage>1029</fpage>
          <lpage>1035</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199404143301501</pub-id>
          <pub-id pub-id-type="pmid">8127329</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leeuwen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boekhoorn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vingerling</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Witteman</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Klaver</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Hofman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jong</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
          <article-title>Dietary intake of antioxidants and risk of age-related macular degeneration</article-title>
          <source>JAMA</source>
          <year>2005</year>
          <volume>294</volume>
          <fpage>3101</fpage>
          <lpage>3107</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.294.24.3101</pub-id>
          <pub-id pub-id-type="pmid">16380590</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="other">Evans JR (2006) Antioxidant vitamin and mineral supplements for slowing the progression of age related macular degeneration. Cochrane Database Syst Rev (2):CD000254</mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sujak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gabrielska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Grudzinski</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Borc</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects</article-title>
          <source>Arch Biochem Biophys</source>
          <year>1999</year>
          <volume>371</volume>
          <fpage>301</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="doi">10.1006/abbi.1999.1437</pub-id>
          <pub-id pub-id-type="pmid">10545218</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenthal</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Monastario</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dose-ranging study of lutein supplementation in persons aged 60&#xA0;years or older</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>5227</fpage>
          <lpage>5233</lpage>
          <pub-id pub-id-type="doi">10.1167/iovs.05-1513</pub-id>
          <pub-id pub-id-type="pmid">17122107</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitehead</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Mares</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Danis</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Macular pigment: a review of current knowledge</article-title>
          <source>Arch Ophthalmol</source>
          <year>2006</year>
          <volume>124</volume>
          <fpage>1038</fpage>
          <lpage>1045</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.124.7.1038</pub-id>
          <pub-id pub-id-type="pmid">16832030</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moeller</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Parekh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tinker</surname>
              <given-names>L</given-names>
            </name>
            <collab>CAREDS Research Study Group</collab>
            <etal/>
          </person-group>
          <article-title>Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS): ancillary study of the Women&#x2019;s Health Initiative</article-title>
          <source>Arch Ophthalmol</source>
          <year>2006</year>
          <volume>124</volume>
          <fpage>1151</fpage>
          <lpage>1162</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.124.8.1151</pub-id>
          <pub-id pub-id-type="pmid">16908818</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delcourt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carri&#xE8;re</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Delage</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barberger-Gateau</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schalch</surname>
              <given-names>W</given-names>
            </name>
            <collab>the POLA Study Group</collab>
          </person-group>
          <article-title>Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA study</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>2329</fpage>
          <lpage>2335</lpage>
          <pub-id pub-id-type="doi">10.1167/iovs.05-1235</pub-id>
          <pub-id pub-id-type="pmid">16723441</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gale</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Martyn</surname>
              <given-names>CN</given-names>
            </name>
          </person-group>
          <article-title>Lutein and zeaxanthin status and risk of age-related macular degeneration</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>2461</fpage>
          <lpage>2465</lpage>
          <pub-id pub-id-type="doi">10.1167/iovs.02-0929</pub-id>
          <pub-id pub-id-type="pmid">12766044</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trumbo</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Ellwood</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration&#x2019;s evidence-based review system for health claims</article-title>
          <source>Am J Clin Nutr</source>
          <year>2006</year>
          <volume>84</volume>
          <fpage>971</fpage>
          <lpage>974</lpage>
          <pub-id pub-id-type="pmid">17093145</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coleman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chew</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Nutritional supplementation in age-related macular degeneration</article-title>
          <source>Curr Opinion Ophthalmol</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>220</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="doi">10.1097/ICU.0b013e32814a586b</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="other">AREDS2 website. <ext-link ext-link-type="uri" xlink:href="http://www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=120">http://www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=120</ext-link>. Accessed 15 December 2009</mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hathcock</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
          <article-title>Risk assessment for the carotenoids lutein and lycopene</article-title>
          <source>Regul Toxicol Pharmacol</source>
          <year>2006</year>
          <volume>45</volume>
          <fpage>289</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yrtph.2006.05.007</pub-id>
          <pub-id pub-id-type="pmid">16814439</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mozaffarian</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rimm</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Fish intake, contaminants, and human health: evaluating the risks and the benefits</article-title>
          <source>JAMA</source>
          <year>2006</year>
          <volume>296</volume>
          <fpage>1885</fpage>
          <lpage>1899</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.296.15.1885</pub-id>
          <pub-id pub-id-type="pmid">17047219</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Bang</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Dyerberg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Draper</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Lipid metabolism and ischaemic heart disease in Greenland Eskimos</article-title>
          <source>Advances in nutrition research</source>
          <year>1980</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Plenum Press</publisher-name>
          <fpage>1</fpage>
          <lpage>22</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seddon</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Gensler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Milton</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Rifai</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Association between C-reactive protein and age-related macular degeneration</article-title>
          <source>JAMA</source>
          <year>2004</year>
          <volume>291</volume>
          <fpage>704</fpage>
          <lpage>710</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.291.6.704</pub-id>
          <pub-id pub-id-type="pmid">14871913</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edwards</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Abel</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Panhuysen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Farrer</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Complement factor H polymorphism and age-related macular degeneration</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <fpage>421</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1110189</pub-id>
          <pub-id pub-id-type="pmid">15761121</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Zeiss</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chew</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complement factor H polymorphism in age-related macular degeneration</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <fpage>385</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1109557</pub-id>
          <pub-id pub-id-type="pmid">15761122</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hageman</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>LV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>7227</fpage>
          <lpage>7232</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0501536102</pub-id>
          <pub-id pub-id-type="pmid">15870199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haines</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complement factor H variant increases the risk of age-related macular degeneration</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <fpage>419</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1110359</pub-id>
          <pub-id pub-id-type="pmid">15761120</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horrocks</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>YK</given-names>
            </name>
          </person-group>
          <article-title>Health benefits of docosahexaenoic acid (DHA)</article-title>
          <source>Pharmacol Res</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>211</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="doi">10.1006/phrs.1999.0495</pub-id>
          <pub-id pub-id-type="pmid">10479465</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hodge</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Schachter</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy of &#x3C9;-3 fatty acids in preventing age-related macular degeneration: a systematic review</article-title>
          <source>Ophthalmology</source>
          <year>2006</year>
          <volume>113</volume>
          <fpage>1165</fpage>
          <lpage>1173</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2006.02.043</pub-id>
          <pub-id pub-id-type="pmid">16815401</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seddon</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosner</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of age-related macular degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>2006</year>
          <volume>124</volume>
          <fpage>995</fpage>
          <lpage>1001</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.124.7.995</pub-id>
          <pub-id pub-id-type="pmid">16832023</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carroll</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Evidence for the cardioprotective effects of omega-3 fatty acids</article-title>
          <source>Ann Pharmacother</source>
          <year>2002</year>
          <volume>36</volume>
          <fpage>1950</fpage>
          <lpage>1956</lpage>
          <pub-id pub-id-type="doi">10.1345/aph.1A314</pub-id>
          <pub-id pub-id-type="pmid">12452760</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eritsland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Arnesen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gronseth</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fjeld</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Abdelnoor</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency</article-title>
          <source>Am J Cardiol</source>
          <year>1996</year>
          <volume>77</volume>
          <fpage>31</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9149(97)89130-8</pub-id>
          <pub-id pub-id-type="pmid">8540453</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leaf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>AK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Do fish oils prevent restenosis after coronary angioplasty?</article-title>
          <source>Circulation</source>
          <year>1994</year>
          <volume>90</volume>
          <fpage>2248</fpage>
          <lpage>2257</lpage>
          <pub-id pub-id-type="pmid">7955181</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bender</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Kraynak</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Chiquette</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Linn</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Bussey</surname>
              <given-names>HI</given-names>
            </name>
          </person-group>
          <article-title>Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy</article-title>
          <source>J Thromb Thrombolysis</source>
          <year>1998</year>
          <volume>5</volume>
          <fpage>257</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1008852127668</pub-id>
          <pub-id pub-id-type="pmid">10767122</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="other">US Department of Health and Human Services, US Environmental Protection Agency. What you need to know about mercury in fish and shellfish. CFSAN Website. Available at <ext-link ext-link-type="uri" xlink:href="http://www.cfsan.fda.gov/dms/admehg3.html">http://www.cfsan.fda.gov/dms/admehg3.html</ext-link>. Accessed 15 December 2007</mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foran</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Flood</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Lewandrowski</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2003</year>
          <volume>127</volume>
          <fpage>1603</fpage>
          <lpage>1605</lpage>
          <pub-id pub-id-type="pmid">14632570</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Good news! These supplements have omega-3&#x2019;s without contaminants found in fish! But some are better than others. Find out now! [report.] ConsumerLab.com Website. Available at <ext-link ext-link-type="uri" xlink:href="http://www.consumerlab.com/results/omega3.asp">http://www.consumerlab.com/results/omega3.asp</ext-link>. Accessed 15 December 2007</mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <mixed-citation publication-type="other">Dietary Guidance, National Agricultural Library, United States Department of Agriculture website. <ext-link ext-link-type="uri" xlink:href="http://riley.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=2&amp;tax_subject=256&amp;topic_id=1342">http://riley.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=2&amp;tax_subject=256&amp;topic_id=1342</ext-link>. Accessed 15 December 2007</mixed-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A review of research actuality on age-related macular degeneration</article-title>
          <source>Yan Ke Xue Bao</source>
          <year>2001</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>245</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="pmid">12567516</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liakopoulos</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The photoprotective role of epidermal anthocyanins and surface pubescence in young leaves of grapevine (<italic>Vitis vinifera</italic>)</article-title>
          <source>Ann Bot (Lond)</source>
          <year>2006</year>
          <volume>98</volume>
          <issue>1</issue>
          <fpage>257</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="doi">10.1093/aob/mcl097</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bagchi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Bagchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Atalay</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula</article-title>
          <source>Biochemistry (Mosc)</source>
          <year>2004</year>
          <volume>69</volume>
          <issue>1</issue>
          <fpage>75</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1023/B:BIRY.0000016355.19999.93</pub-id>
          <pub-id pub-id-type="pmid">14972022</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadilova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Carle</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stintzing</surname>
              <given-names>FC</given-names>
            </name>
          </person-group>
          <article-title>Thermal degradation of anthocyanins and its impact on color and in vitro antioxidant capacity</article-title>
          <source>Mol Nutr Food Res</source>
          <year>2007</year>
          <volume>51</volume>
          <issue>12</issue>
          <fpage>1461</fpage>
          <lpage>1471</lpage>
          <pub-id pub-id-type="doi">10.1002/mnfr.200700179</pub-id>
          <pub-id pub-id-type="pmid">17979100</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bagchi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety and whole-body antioxidant potential of a novel anthocyanin-rich formulation of edible berries</article-title>
          <source>Mol Cell Biochem</source>
          <year>2006</year>
          <volume>281</volume>
          <issue>1&#x2013;2</issue>
          <fpage>197</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="doi">10.1007/s11010-006-1030-6</pub-id>
          <pub-id pub-id-type="pmid">16328973</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faria</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gameiro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Santos-Buelga</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mateus</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Antioxidant properties of prepared blueberry (<italic>Vaccinium myrtillus</italic>) extracts</article-title>
          <source>J Agric Food Chem</source>
          <year>2005</year>
          <volume>53</volume>
          <issue>17</issue>
          <fpage>6896</fpage>
          <lpage>6902</lpage>
          <pub-id pub-id-type="doi">10.1021/jf0511300</pub-id>
          <pub-id pub-id-type="pmid">16104817</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Blanchette</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Michaud-Levesque</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lafleur</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Durocher</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Moghrabi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barrette</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gingras</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Beliveau</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation</article-title>
          <source>Carcinogenesis</source>
          <year>2006</year>
          <volume>27</volume>
          <issue>5</issue>
          <fpage>989</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="doi">10.1093/carcin/bgi279</pub-id>
          <pub-id pub-id-type="pmid">16308314</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khanna</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alessio</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Vider</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bagchi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bagchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>CK</given-names>
            </name>
          </person-group>
          <article-title>Anti-angiogenic property of edible berries</article-title>
          <source>Free Radic Res</source>
          <year>2002</year>
          <volume>36</volume>
          <issue>9</issue>
          <fpage>1023</fpage>
          <lpage>1031</lpage>
          <pub-id pub-id-type="doi">10.1080/1071576021000006662</pub-id>
          <pub-id pub-id-type="pmid">12448828</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomany</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Leeuwen</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors for incident age-related macular degeneration: pooled findings from 3 continents</article-title>
          <source>Ophthalmology</source>
          <year>2004</year>
          <volume>111</volume>
          <fpage>1280</fpage>
          <lpage>1287</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2003.11.010</pub-id>
          <pub-id pub-id-type="pmid">15234127</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="other">The health consequences of smoking: a report of the surgeon general, 2005. <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/tobacco/sgr/sgr_2004/index.htm">http://www.cdc.gov/tobacco/sgr/sgr_2004/index.htm</ext-link>. Accessed 15 December 2007</mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Age-Related Eye Disease Study Research Group</collab>
          </person-group>
          <article-title>Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report No. 19</article-title>
          <source>Ophthalmology</source>
          <year>2005</year>
          <volume>112</volume>
          <fpage>533</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2004.10.047</pub-id>
          <pub-id pub-id-type="pmid">15808240</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seddon</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Cote</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rosner</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio</article-title>
          <source>Arch Ophthalmol</source>
          <year>2003</year>
          <volume>121</volume>
          <fpage>785</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.121.6.785</pub-id>
          <pub-id pub-id-type="pmid">12796248</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Eye Disease Case-Control Study Group</collab>
          </person-group>
          <article-title>Risk factors for neovascular age related macular degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>1992</year>
          <volume>110</volume>
          <fpage>1701</fpage>
          <lpage>1708</lpage>
          <pub-id pub-id-type="pmid">1281403</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Age-Related Eye Disease Study Research Group</collab>
          </person-group>
          <article-title>Risk factors associated with age-related macular degeneration</article-title>
          <source>Ophthalmology</source>
          <year>2000</year>
          <volume>107</volume>
          <fpage>2224</fpage>
          <lpage>2232</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(00)00409-7</pub-id>
          <pub-id pub-id-type="pmid">11097601</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Clegg</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>LS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study</article-title>
          <source>Arch Ophthalmol</source>
          <year>1999</year>
          <volume>117</volume>
          <fpage>1203</fpage>
          <lpage>1210</lpage>
          <pub-id pub-id-type="pmid">10496392</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>BEK</given-names>
            </name>
            <name>
              <surname>Tomany</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study</article-title>
          <source>Am J Epidemiol</source>
          <year>2002</year>
          <volume>156</volume>
          <fpage>589</fpage>
          <lpage>598</lpage>
          <pub-id pub-id-type="doi">10.1093/aje/kwf092</pub-id>
          <pub-id pub-id-type="pmid">12244027</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Bressler</surname>
              <given-names>NM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exposure to sunlight and other risk factors for age-related macular degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>1989</year>
          <volume>107</volume>
          <fpage>875</fpage>
          <lpage>879</lpage>
          <pub-id pub-id-type="pmid">2786410</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The long-term effect of visual light to the eye</article-title>
          <source>Arch Ophthalmol</source>
          <year>1992</year>
          <volume>110</volume>
          <fpage>99</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">1731731</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cruickshanks</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>BEK</given-names>
            </name>
          </person-group>
          <article-title>Sunlight and age-related macular degeneration: the Beaver Dam Eye Study</article-title>
          <source>Arch Ophthalmol</source>
          <year>1993</year>
          <volume>111</volume>
          <fpage>514</fpage>
          <lpage>518</lpage>
          <pub-id pub-id-type="pmid">8470986</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cruickshanks</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>BEK</given-names>
            </name>
            <name>
              <surname>Nondahl</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study</article-title>
          <source>Arch Ophthalmol</source>
          <year>2001</year>
          <volume>119</volume>
          <fpage>246</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">11176987</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darzins</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Heller</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Sun exposure and age-related macular degeneration: an Australian case-control study</article-title>
          <source>Ophthalmology</source>
          <year>1997</year>
          <volume>104</volume>
          <fpage>770</fpage>
          <lpage>776</lpage>
          <pub-id pub-id-type="pmid">9160021</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Iris color, skin sun sensitivity, and age-related maculopathy: the Blue Mountains Eye Study</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume>105</volume>
          <fpage>1359</fpage>
          <lpage>1363</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(98)98013-7</pub-id>
          <pub-id pub-id-type="pmid">9709743</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delcourt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carriere</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ponton-Sanchez</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Light exposure and the risk of age-related macular degeneration</article-title>
          <source>Arch Ophthalmol</source>
          <year>2001</year>
          <volume>119</volume>
          <fpage>1463</fpage>
          <lpage>1468</lpage>
          <pub-id pub-id-type="pmid">11594945</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomany</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Cruickshanks</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Beaver Dam Eye Study: sunlight and the 10-year incidence of age-related maculopathy</article-title>
          <source>Arch Ophthalmol</source>
          <year>2004</year>
          <volume>122</volume>
          <fpage>750</fpage>
          <lpage>757</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.122.5.750</pub-id>
          <pub-id pub-id-type="pmid">15136324</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study</article-title>
          <source>Arch Ophthalmol</source>
          <year>2002</year>
          <volume>120</volume>
          <fpage>1551</fpage>
          <lpage>1558</lpage>
          <pub-id pub-id-type="pmid">12427071</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies</article-title>
          <source>Ophthalmology</source>
          <year>2003</year>
          <volume>110</volume>
          <fpage>1960</fpage>
          <lpage>1967</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(03)00816-9</pub-id>
          <pub-id pub-id-type="pmid">14522772</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freeman</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies</article-title>
          <source>Am J Ophthalmol</source>
          <year>2003</year>
          <volume>135</volume>
          <fpage>849</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(02)02253-5</pub-id>
          <pub-id pub-id-type="pmid">12788126</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boettner</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Wolter</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Transmission of the ocular media</article-title>
          <source>Invest Ophthalmol</source>
          <year>1962</year>
          <volume>1</volume>
          <fpage>776</fpage>
          <lpage>783</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mainster</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Violet and blue light blocking intraocular lenses: photoprotection versus photoreception</article-title>
          <source>Br J Ophthalmol</source>
          <year>2006</year>
          <volume>90</volume>
          <fpage>784</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.2005.086553</pub-id>
          <pub-id pub-id-type="pmid">16714268</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cugati</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rochtchina</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cataract surgery and the 10-year incidence of age-related maculopathy: The Blue Mountain Eye Study</article-title>
          <source>Ophthalmology</source>
          <year>2006</year>
          <volume>113</volume>
          <fpage>2020</fpage>
          <lpage>2025</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2006.05.047</pub-id>
          <pub-id pub-id-type="pmid">16935334</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mainster</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The spectra, classification, and rationale of ultraviolet-protective intraocular lenses</article-title>
          <source>Am J Ophthalmol</source>
          <year>1986</year>
          <volume>102</volume>
          <fpage>727</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="pmid">3789053</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braunstein</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Sparrow</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>A blue-blocking intraocular lens should be used in cataract surgery</article-title>
          <source>Arch Ophthalmol</source>
          <year>2005</year>
          <volume>123</volume>
          <fpage>547</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.123.4.547</pub-id>
          <pub-id pub-id-type="pmid">15824231</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pollack</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marcovich</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bukelman</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation</article-title>
          <source>Ophthalmology</source>
          <year>1996</year>
          <volume>103</volume>
          <fpage>1546</fpage>
          <lpage>1554</lpage>
          <pub-id pub-id-type="pmid">8874425</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparrow</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Blue light absorbing intraocular lens and retinal pigment epithelium protection in vivo</article-title>
          <source>J Cat Refract Surg</source>
          <year>2004</year>
          <volume>30</volume>
          <fpage>873</fpage>
          <lpage>878</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcrs.2004.01.031</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <mixed-citation publication-type="other">Alcon Laboratories 1 (2003) AcrySof Natural Single-Piece IOL Product Monograph. Alcon Laboratories 1, Fort Worth</mixed-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mainster</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Timberlake</surname>
              <given-names>GT</given-names>
            </name>
          </person-group>
          <article-title>Why HID headlights bother older drivers</article-title>
          <source>Br J Ophthalmol</source>
          <year>2003</year>
          <volume>87</volume>
          <fpage>113</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.87.1.113</pub-id>
          <pub-id pub-id-type="pmid">12488274</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Greenstein</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kline</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Owsley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Waxler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hitchins</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>Optical radiation and the aged eye</article-title>
          <source>Optical radiation and visual health</source>
          <year>1986</year>
          <publisher-loc>Boca Raton</publisher-loc>
          <publisher-name>CRC Press</publisher-name>
          <fpage>43</fpage>
          <lpage>67</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fez</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Luque</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Viqueira</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Enhancement of contrast sensitivity and losses of chromatic discrimination with tinted lenses</article-title>
          <source>Optom Vis Sci</source>
          <year>2002</year>
          <volume>79</volume>
          <fpage>590</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="doi">10.1097/00006324-200209000-00010</pub-id>
          <pub-id pub-id-type="pmid">12322929</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolffsohn</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Cochrane</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Khoo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshimitsu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Contrast is enhanced by yellow lenses because of selective reduction of short-wavelength light</article-title>
          <source>Optom Vis Sci</source>
          <year>2000</year>
          <volume>77</volume>
          <fpage>73</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1097/00006324-200002000-00011</pub-id>
          <pub-id pub-id-type="pmid">10701805</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wiley</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Differences in apparent contrast in yellow and white light</article-title>
          <source>Ophthalmic Physiol Opt</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>68</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1016/0275-5408(94)00009-3</pub-id>
          <pub-id pub-id-type="pmid">8729569</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <mixed-citation publication-type="other">Cionni RJ (2004) Color perception in patients with UV or blue-light-filtering IOLs. In: Symposium on cataract, IOL and refractive surgery. American Society of Cataract and Refractive Surgery, San Diego. Abstract 337</mixed-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <mixed-citation publication-type="other">Tjia K (2004) AcrySof Natural SN60 and clear SA60 IOLs: intraindividual comparison. In: Symposium on cataract, IOL and refractive surgery. American Society of Cataract and Refractive Surgery, San Diego. Abstract 426</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
